- Overview
- Experience
Introduction
Chris is an experienced patent litigator who focuses on Hatch-Waxman and life sciences patent litigation.
Christopher D. Jones represents leading life sciences and pharmaceutical companies in complex, high-stakes patent litigation proceedings. Chris has extensive experience with Hatch-Waxman litigation, including cases involving Abbreviated New Drug Applications (ANDAs) and 505(b)(2) applications. He also advises clients on the U.S. Food and Drug Administration approval process for both drug products and medical devices and helps clients address strategic considerations at the intersection of regulatory and patent law.
Beyond Hatch-Waxman litigation, Chris handles patent disputes in U.S. District Courts, before the Patent Trial and Appeal Board and the International Trade Commission, and in the U.S. Court of Appeals for the Federal Circuit. His experience also includes patent-related matters before U.S. Customs and Border Protection.
Chris has a diverse background in both chemical and biochemical technologies, including pharmaceutical chemistry, organic chemistry, biochemistry, polymer chemistry, and cell biology. His graduate school research focused on drug development and formulation, specifically the development of solid and crystalline forms of new and existing drug compounds.
While earning his J.D. at George Mason University School of Law, Chris worked as a patent agent and technology specialist, where he assisted patent attorneys with opinion preparation and patent prosecution matters. He was a member of the Intellectual Property Law Society and graduated with a concentration in IP law.
Areas of focus
Education & credentials
- George Mason, Antonin Scalia Law School, J.D., 2018
- University of South Florida, M.A., Chemistry, 2014
- High Point University, B.S., Chemistry, 2012
-
District of Columbia
-
U.S. Patent and Trademark Office
-
U.S. Court of Appeals for the Federal Circuit
-
Polsinelli, Washington D.C., Associate, 2025-2026
-
Ashurst Perkins Coie LLP US (then Perkins Coie), Washington D.C., Associate, 2019-2025
-
Kramer IP Search, Washington D.C., Chem/Bio Technology Specialist, 2014-2019
Celgene Corporation v. Dr. Reddy's Laboratories, Ltd. et. al.
U.S. District Court for the District of New Jersey
Representing Dr. Reddy’s Laboratories in two Hatch-Waxman litigations in the District of New Jersey, contesting validity and infringement of formulation patents and method-of-treatment patents relating to pomalidomide (Pomalyst®). Cases are ongoing.
Novartis Pharmaceuticals Corporation v. Dr. Reddy’s Laboratories, Inc.
U.S. District Court for the District of Delaware
Representing Dr. Reddy’s Laboratories in Hatch-Waxman litigation in the District of Delaware, contesting the validity and infringement of patents relating to sacubitril/valsartan (Entresto®). Case is ongoing.